Idexx Laboratories (IDXX) Capital Expenditures (2009 - 2026)

Idexx Laboratories' Capital Expenditures history runs 18 years deep, the most recent figure standing at $32.0 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 198.86% year-over-year to $32.0 million; the TTM figure through Mar 2026 stood at $146.0 million (up 44.01% YoY), while the FY2025 annual figure was $124.7 million, up 3.1% from the prior year.
• Capital Expenditures for Q1 2026 stood at $32.0 million, up from $29.4 million in the prior quarter.
• The five-year high for Capital Expenditures was $129.2 million in Q4 2022, with the low at -$24.1 million in Q2 2023.
• The 5-year median for Capital Expenditures is $30.3 million (2024), against an average of $32.9 million.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures tumbled 159.47% in 2022, then soared 818.65% in 2023.
• Idexx Laboratories' Capital Expenditures stood at $129.2 million in 2022, then tumbled by 74.8% to $32.6 million in 2023, then decreased by 10.14% to $29.3 million in 2024, then grew by 0.61% to $29.4 million in 2025, then grew by 8.66% to $32.0 million in 2026.
• Business Quant data shows IDXX's Capital Expenditures at $32.0 million in Q1 2026, $29.4 million in Q4 2025, and $86.8 million in Q3 2025.